NEONasdaqServices-Testing LaboratoriesFiscal year ends December 31
NEOGENOMICS INC
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 28, 2026
$16.42−0.23 (-1.38%)
Close on Oct 19, 2026
- Market cap
- $2.15B
- P/E (TTM)
- –
- Dividend yield
- –
NEOGENOMICS INC revenue by segment
By business segment
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reportable Segment | $727.33M | $660.57M | $591.64M | $509.73M | – | – | – | – | – | – | 100.0% | +10.1% |
| Clinical Services | – | – | – | $418.75M | $404.17M | $382.34M | $361.16M | $241.87M | $213.10M | $210.16M | – | – |
| Pharma Services | – | – | – | $90.97M | $80.16M | $62.11M | $47.67M | $34.87M | $27.15M | $21.65M | – | – |
| Clinical Services | – | – | $495.64M | $418.75M | $404.17M | $382.34M | $361.16M | $241.87M | $213.10M | $210.16M | – | – |
| Advanced Diagnostics | – | – | – | $90.97M | $80.16M | $62.11M | $47.67M | $34.87M | $27.15M | $21.65M | – | – |
| Advanced Diagnostics | – | – | $96.01M | $90.97M | $80.16M | – | – | – | – | – | – | – |
By product or service
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Client direct billing | $518.84M | $475.44M | $428.90M | $370.71M | – | – | – | – | – | – | 71.3% | +9.1% |
| Commercial insurance | $117.51M | $99.84M | $88.02M | $73.28M | – | – | – | – | – | – | 16.2% | +17.7% |
| Medicare and other government | $90.87M | $84.60M | $74.37M | $65.59M | – | – | – | – | – | – | 12.5% | +7.4% |
| Self-pay | $114.00K | $681.00K | $350.00K | $157.00K | – | – | – | – | – | – | 0.0% | -83.3% |
By region
From the segment and revenue-disaggregation notes of Neogenomics's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.